These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 8492755)

  • 1. Re: "Etoposide in the treatment of six children with Langerhans cell histiocytosis (histiocytosis X)" by Viana et al.
    Whitlock JA
    Med Pediatr Oncol; 1993; 21(5):379. PubMed ID: 8492755
    [No Abstract]   [Full Text] [Related]  

  • 2. Langerhans cell histiocytosis and etoposide: risks vs. benefits.
    D'Angio GJ
    Med Pediatr Oncol; 1994; 23(2):69-71. PubMed ID: 8202044
    [No Abstract]   [Full Text] [Related]  

  • 3. Increased risk of secondary leukemia after single-agent treatment with etoposide for Langerhans' cell histiocytosis.
    Haupt R; Fears TR; Rosso P; Colella R; Loiacono G; de Terlizzi M; Mancini A; Comelli A; Indolfi P; Donfrancesco A
    Pediatr Hematol Oncol; 1994; 11(5):499-507. PubMed ID: 7826846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. VP-16 and the treatment of histiocytosis.
    Gadner H; Ladisch S; Aricó M; Broadbent V; Jakobson A; Komp D; Nicholson S
    Eur J Pediatr; 1994 May; 153(5):389. PubMed ID: 8033933
    [No Abstract]   [Full Text] [Related]  

  • 5. Secondary acute myelocytic leukemia after successful chemotherapy with etoposide for Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
    Kitazawa J; Ito E; Arai K; Yokoyama M; Fukayama M; Imashuku S
    Med Pediatr Oncol; 2001 Aug; 37(2):153-4. PubMed ID: 11496359
    [No Abstract]   [Full Text] [Related]  

  • 6. Etoposide in the treatment of six children with Langerhans cell histiocytosis (histiocytosis X).
    Viana MB; Oliveira BM; Silva CM; Rios Leite VH
    Med Pediatr Oncol; 1991; 19(4):289-94. PubMed ID: 1669481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Etoposide and Langerhans cell histiocytosis: second malignancies, a second look.
    Felix CA; Blatt J
    Pediatr Hematol Oncol; 1999; 16(3):183-5. PubMed ID: 10326216
    [No Abstract]   [Full Text] [Related]  

  • 8. Etoposide in Langerhans cell histiocytosis.
    Gadner H
    Pediatr Hematol Oncol; 1996; 13(4):309-11. PubMed ID: 8837135
    [No Abstract]   [Full Text] [Related]  

  • 9. Etoposide (VP16) in the treatment of multisystem Langerhans cell histiocytosis (histiocytosis X).
    Broadbent V; Pritchard J; Yeomans E
    Med Pediatr Oncol; 1989; 17(2):97-100. PubMed ID: 2784842
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etoposide in Langerhans cell histiocytosis in children: a preliminary experience.
    Basade MM; Nair CN; Kurkure PA; Pai SK; Advani SH
    Pediatr Hematol Oncol; 1996; 13(2):159-62. PubMed ID: 8721030
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LCH-I: a randomized trial of etoposide vs. vinblastine in disseminated Langerhans cell histiocytosis. The Histiocyte Society.
    Ladisch S; Gadner H; Aricò M; Broadbent V; Grois N; Jacobson A; Komp D; Nicholson HS
    Med Pediatr Oncol; 1994; 23(2):107-10. PubMed ID: 8202031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Translocation (11;11)(p13- p15;q23) in a child with therapy-related acute myeloid leukemia following chemotherapy with DNA-topoisomerase II inhibitors for Langerhans cell histiocytosis.
    Silva ML; Land MG; Maradei S; Otero L; Veith M; Brito G; Klumb C; Fernandez T; Pombo-de-Oliveira MS
    Cancer Genet Cytogenet; 2002 May; 135(1):101-2. PubMed ID: 12072208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute promyelocytic leukemia with t(15;17) abnormality after chemotherapy containing etoposide for Langerhans' cell histiocytosis.
    López-Andreu JA; Ferris J; Verdeguer A; Esquembre C; Castel V
    Cancer; 1994 Sep; 74(5):1650-2. PubMed ID: 7864932
    [No Abstract]   [Full Text] [Related]  

  • 14. Acute promyelocytic leukaemia in a patient treated with etoposide for Langerhans cell histiocytosis.
    Matsuzaki A; Inamitsu T; Watanabe T; Ohga S; Ishii E; Nagotoshi Y; Tasaka H; Suda M; Ueda K
    Br J Haematol; 1994 Apr; 86(4):887-9. PubMed ID: 7918090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of secondary leukemia after treatment with etoposide (VP-16) for Langerhans' cell histiocytosis in Italian and Austrian-German populations.
    Haupt R; Fears TR; Heise A; Gadner H; Loiacono G; De Terlizzi M; Tucker MA
    Int J Cancer; 1997 Mar; 71(1):9-13. PubMed ID: 9096658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acute myeloid leukemia after single-agent treatment with etoposide for Langerhans' cell histiocytosis of bone.
    Haupt R; Comelli A; Rosanda C; Sessarego M; De Bernardi B
    Am J Pediatr Hematol Oncol; 1993 May; 15(2):255-7. PubMed ID: 8498650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Secondary acute promyelocytic leukemia after treatment with etoposide for Langerhans cell histiocytosis (LCH).
    Lopes LF; de Camargo B
    Med Pediatr Oncol; 1999 Apr; 32(4):315. PubMed ID: 10102032
    [No Abstract]   [Full Text] [Related]  

  • 18. Treatment of Langerhans cell histiocytosis in children with etoposide.
    Ishii E; Matsuzaki A; Okamura J; Inoue T; Kajiwara M; Uozumi T; Yoshida N; Miyazaki S; Miyake K; Matsumoto T
    Am J Clin Oncol; 1992 Dec; 15(6):515-7. PubMed ID: 1449115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Langerhans-cell histiocytosis--excellent response to etoposide.
    Mayou SC; Chu AC; Munro DD; Plowman N
    Clin Exp Dermatol; 1991 Jul; 16(4):292-4. PubMed ID: 1794174
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Etoposide (VP16) treatment of Langerhans-cell histiocytosis].
    Pedrol E; Estruch R; Marrades RM; Ingelmo M
    Rev Clin Esp; 1991 Apr; 188(6):319. PubMed ID: 1780535
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.